DrugInfoAssn

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from DrugInfoAssn, 21 Dupont Cir NW, Washington D.C., DC.

DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, policy makers, and thought leaders in a neutral, transparent environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have impacted healthcare outcomes by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities. DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan).

03/28/2026

Pitch. Validate. Scale.

The LIFT Series + Whale Tank at DIA 2026 Global Annual Meeting is a customer-first pitch program for early-stage biotech and clintech companies ready to test their value with the people who matter most.

Unlike typical pitch competitions, Whale Tank prioritizes real-world market feedback from customers, strategic partners, regulators, and investors—often leading to meaningful follow-up conversations long after the pitch.

If you’re building solutions across therapeutics, diagnostics, discovery, or clinical development, this is your moment to be seen, challenged, and validated live, at DIA’s Global Annual Meeting in Philadelphia this June.

🐋 (Stuffed whales included.)

Applications close April 10th!

Learn more and apply here: https://eu1.hubs.ly/H0t2cLM0

03/25/2026

Maximize your DIA 2026 experience with Short Courses 🧠 Before kicks off in Philadelphia (June 14–18), dive deep into the topics shaping life sciences, from real-world evidence and AI governance to cell and gene therapy regulations.

8 courses. CE credit available. No full conference registration required.

Whether you join virtually the week before or in-person on June 12, these focused sessions offer practical frameworks you can apply immediately.

Topics include:
→ Real-World Evidence for Regulatory Decision-Making
→ AI Applications, Ethics & Governance for Life Sciences
→ Cell and Gene Therapies 101
→ Regulatory Strategy for Devices & Combination Products
→ Root Cause Analysis & CAPA Management

Attend a short course 👉 https://eu1.hubs.ly/H0sXmgc0

03/10/2026

Why do people keep coming back to the DIA Global Annual Meeting?

The connections.
The collaboration.
The impact on patients worldwide.

Here’s one perspective from our community. 👇

Now we’d love to hear yours.

Tell us your and register by March 12th (this Thursday!) to get your ticket at the Advanced Rate before prices increase!

02/18/2026

23rd DIA Japan Annual Meeting 2026 - Crossing Boundaries, Shaping a Future Beyond Imagination with Innovation
📅 18-20 October 2026
📍 Tokyo Big Sight

The Call for Abstracts is now open. This premier meeting, organised by DIA Japan, brings together global experts to advance innovation across healthcare and life sciences.

Session Submissions:
◾ Submission deadline: Friday, 27 March 2026.
◾ Submit here: https://ow.ly/ek8N50YhE49.

Poster Presentations:
◾ Submission deadline: Friday, 26 June 2026.
◾ Submit here: https://ow.ly/1vty50YhE47.

Full meeting details and guidelines are available here: https://ow.ly/AsG650YhE4b.

02/03/2026

Join DXC at DIA RSIDM 2026 booth #106 and learn how Regulatory Practitioners can navigate this critical point for regulatory organizations as the industry adopts eCTD 4.0, growing submission volumes and pressure to modernize with AI while maintaining compliance.
https://ow.ly/5NGW50Y7w1l

DXC's workflow agents help

01/23/2026

DIA Conference Jan 26-28 is next week! Ready to transform your Pharmacovigilance operations? Meet APCER at Booth 101 during DIA 2026! Our healthcare expertise, ISO-certified quality, and end-to-end accountability deliver results you can trust. Connect with our team: https://ow.ly/sZ9150XWe7p

01/13/2026

DIA Conference Jan 26-28 Ready to transform your Pharmacovigilance operations? Meet APCER at Booth 101 during DIA 2026! Our healthcare expertise, ISO-certified quality, and end-to-end accountability deliver results you can trust. Connect with our team: https://ow.ly/sZ9150XWe7p

11/27/2025

We are pleased to announce that the early-bird registration deadline has been extended until December 2.

On Wednesday, December 17, DIA will host two focused educational sessions to help you quickly catch up on essential updates in gene therapy and advanced spatial analysis.

Session 1 (9:30–10:10)
“Assessment of Shedding for Gene Therapy Products Using Viral Vectors”
Speaker: Dr. Teruhide Yamaguchi, Kanazawa Institute of Technology

The public comment period closed in May, and official guidance on “shedding assessment” is expected soon. Dr. Yamaguchi, who helped draft the document, will explain its key points in 40 minutes:

What needs to be assessed, and by when?
How does this differ from Cartagena Law evaluations?
If you work with viral vectors, fresh information is critical. Attend in person and you may ask questions directly.

Session 2 (13:10–13:40)
“Capturing Drug Candidate Mechanisms in Spatial Context: New Frontiers in Single-Cell and Spatial Analysis”
Speaker: Dr. Toru Uchiyama, National Center for Child Health and Development

From single-cell to spatial—drug discovery is entering a new era. Advances in next-generation sequencing (NGS) are revolutionary. As research accelerates from bulk → single-cell → spatial analysis, Dr. Uchiyama will cover:

Why is spatial analysis a game-changer?
What insights emerge from combining cell location and gene expression?
How far has its application to AAV gene therapy progressed?
In just 30 minutes, broaden your perspective on drug discovery.

December 17 will be a day to accelerate your knowledge update. Don’t miss this chance to gain fresh insights and new perspectives. We look forward to your participation!
An on-demand recording will be available at a later date. Please consider this option as well.

10th DIA Cell and Gene Therapy Products Symposium in Japan:
https://ow.ly/IRXl50XxE8A

11/20/2025

Program Now Available! Highlights of the session‼
Take advantage of our Early Bird Team Rate – register today and save!

We would like to introduce one of Sessions as below.

Session ４: Realizing the True Value of the Conditional and Time Limited Approval System

Highlight sessions at the 10th Anniversary Symposium!

Closing Day 2 is " Realizing the True Value of the Conditional and Time Limited Approval System" which is a perfect theme to conclude the symposium.

Join us to hear real experiences regarding two products approved under this system and one that was not. Plus, in-depth discussions between the PMDA and industry experts. – Only at DIA!

✅ What were the reasons and background behind the approvals and non-approval?

✅What are the remaining challenges of the system and its future prospects for the system to realize its true value?

This is a must-see session for anyone considering the future of regenerative medicine products. Don’t miss this valuable opportunity!

SESSION CHAIR:

Akihiro Kume (RPM Co., Ltd.)
Mizuho Nonaka (Sumitomo Pharma Co.,Ltd.)

SPEAKERS:

Atsushi Nishikawa (Pharmaceuticals and Medical Devices Agency (PMDA))
Kazumi Sawaguchi, PhD (SanBio Company Limited)
Makiko Okada (Chugai Pharmaceutical Co., Ltd.)
Kazuhisa Senshu (Terumo Corporation)

10th DIA Cell and Gene Therapy Products Symposium in Japan:

https://ow.ly/reeA50Xu5yP

11/13/2025

Program Now Available: 10th DIA Cell and Gene Therapy Products Symposium in Japan

[Session Highlight]
Stable Manufacturing of Cellular Therapeutic Products: Towards Consistent Manufacturing Processes Throughout the Product Lifecycle
This session aims to ensure consistent manufacturing across the product lifecycle by explaining and discussing current support measures. The Ministry of Economy, Trade and Industry will first introduce initiatives in regenerative medicine, including promoting the use of CDMOs (Contract Development and Manufacturing Organizations) for pharmaceutical development. Pharmaceutical companies will then share scenarios and challenges in applying core technologies. The ISO/TC 276 Mirror Committee will present an overview and practical use of standards—particularly JIS Q 2101: Cell Manufacturing Process Management System, published in February 2025. Finally, a panel discussion with experts from PMDA and leading CDMOs will explore the adequacy of these support measures.

SESSION CHAIR:
◾ Maki Tanaka Maki Tanaka (Takara Bio Inc.)
◾ Ikuo Kawauchi (FUFIFILM Holdings Corporation)

SPEAKERS:
◾ Shoki Nishio (Ministry of Economy, Trade and Industry(METI))
◾ Mika Yoshimatsu (T Cell Nouveau Inc.)
◾ Ryutaro Hirasawa, PhD (Daiichi Sankyo Co., Ltd.)
◾ Ikuo Kawauchi (FUFIFILM Holdings Corporation)
◾ Ryuji Kato (Tokai National Higher Education and Research System, Nagoya University)

PANELISTS:
◾ Kenichiro Maeda (Pharmaceuticals and Medical Devices Agency (PMDA))
◾ Junichi Mineno (Takara Bio Inc.)

Take advantage of our early bird team rate – register today and save: https://ow.ly/OFK250XqRGX.

11/11/2025

Take advantage of our early bird team rate – register today and save!
Clinical Data Management (CDM) is undergoing a remarkable transformation. With the rise of Digital Transformation (DX) and Artificial Intelligence (AI), the ways we collect, process, and analyze data are evolving rapidly. The use of Real-World Data (RWD) is expanding, and Post-Marketing Surveillance (PMS) is demanding more agile and strategic approaches from CDM professionals. Meanwhile, regulatory frameworks like ICH-GCP continue to evolve, adding new layers of complexity and opportunity.
In this dynamic landscape, the core mission of CDM - ensuring the reliability and integrity of clinical data - remains as vital as ever. As we embrace innovation, we must also ask: “What core values must we preserve while navigating change?”.

Join us at the 29th DIA Japan Annual Workshop for Clinical Data Management to explore this essential question. Through interactive sessions, panel discussions, and Q&A, we’ll dive into key topics including DX and AI, RWD, regulatory adaptation, PMS, quality management, and workforce development.

Hear from experts across industry, government, and academia, and gain insights that bridge real-world practice with future-forward thinking.

Whether you're a professional, leader, educator, regulator, or researcher, this workshop offers a unique opportunity to connect, learn, and co-create practical knowledge for the future of CDM.

🔗 Learn more and register: https://ow.ly/lAzz50XpYE4.

Address

21 Dupont Cir NW
Washington D.C., DC
19044

Website

http://www.DIAglobal.org/

Alerts

Be the first to know and let us send you an email when DrugInfoAssn posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Joseph LaFleur and Associates Psychotherapy a
Telehealth & 2001 L Street NW Ste 500

Want your practice to be the top-listed Clinic in Washington D.C.?

Our Story

DIA (founded as the Drug Information Association) provides a global, neutral forum where life science professionals from across all areas of expertise can join together and engage with patients, peers, and other thought leaders on the issues of today and possibilities of tomorrow. Our Global Annual Meeting is one of the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. The DIA 2020 Global Annual Meeting will host more than 7,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries. DIA 2020 boasts more than 400 exhibiting companies and 250+ sessions across 13 tracks focused on regulatory science, translational medicine, patient engagement, value and access, and more. Follow DIA 2020 updates on Twitter using #DIA2020.